SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 107 filers reported holding SESEN BIO INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $621 | -99.9% | 1,018,956 | -3.5% | 0.00% | 0.0% |
| Q3 2022 | $449,000 | -9.8% | 1,055,791 | +72.0% | 0.00% | 0.0% |
| Q2 2022 | $498,000 | +80.4% | 614,000 | +34.2% | 0.00% | – |
| Q1 2022 | $276,000 | -77.8% | 457,437 | -70.9% | 0.00% | -100.0% |
| Q3 2021 | $1,245,000 | -78.8% | 1,569,685 | +23.7% | 0.00% | -71.4% |
| Q2 2021 | $5,861,000 | -39.9% | 1,268,597 | -66.2% | 0.01% | -41.7% |
| Q1 2021 | $9,745,000 | +148.0% | 3,747,897 | +28.7% | 0.01% | +200.0% |
| Q4 2020 | $3,930,000 | +39.2% | 2,911,018 | +44.3% | 0.00% | +33.3% |
| Q3 2020 | $2,824,000 | +207.0% | 2,016,918 | +57.8% | 0.00% | +200.0% |
| Q2 2020 | $920,000 | +686.3% | 1,278,096 | +513.8% | 0.00% | – |
| Q1 2020 | $117,000 | +290.0% | 208,228 | +1387.3% | 0.00% | – |
| Q3 2018 | $30,000 | -49.2% | 14,000 | -53.4% | 0.00% | – |
| Q2 2018 | $59,000 | – | 30,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 4,091,591 | $18,903,000 | 100.00% |
| Schonfeld Strategic Advisors LLC | 3,828,200 | $17,687,000 | 0.19% |
| Virtus ETF Advisers LLC | 52,632 | $243,000 | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 711,500 | $3,287,000 | 0.06% |
| WealthTrust Axiom LLC | 39,750 | $183,000 | 0.06% |
| CAXTON ASSOCIATES LP | 84,801 | $392,000 | 0.04% |
| Stratos Wealth Partners, LTD. | 352,500 | $1,629,000 | 0.04% |
| ClariVest Asset Management LLC | 260,500 | $1,203,000 | 0.04% |
| TWO SIGMA ADVISERS, LP | 2,766,318 | $12,780,000 | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 3,150,574 | $14,556,000 | 0.03% |